NDC 33342-408 – Dapagliflozin and Metformin Hydrochloride

Dapagliflozin 5 mg/1; Metformin Hydrochloride 1000 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC33342-408

Product details

Brand name
Dapagliflozin and Metformin Hydrochloride
Generic name
Dapagliflozin and Metformin Hydrochloride
Labeler
Macleods Pharmaceuticals Limited
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA211559
Marketed since
April 6, 2026
Listing expires
December 31, 2027
Pharmacologic class
Biguanide; Sodium-Glucose Cotransporter 2 Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Dapagliflozin and metformin hydrochloride →

Package NDC codes (5)

Package NDCDescriptionSince
33342-408-063 BLISTER PACK in 1 CARTON (33342-408-06) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (33342-408-66)Apr 6, 2026
33342-408-0730 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-408-07)Apr 6, 2026
33342-408-0960 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-408-09)Apr 6, 2026
33342-408-1090 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-408-10)Apr 6, 2026
33342-408-15500 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-408-15)Apr 6, 2026

Other Dapagliflozin and metformin hydrochloride products